Skip to content

PTHS PTHS Amortization Of Debt Discount Premium

Amortization Of Debt Discount Premium at other companies

Journey Medical Corporation logo
Journey Medical CorporationDERM

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfDebtDiscountPremium.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's amortization of debt discount premium.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's amortization of debt discount premium?
PTHS (PTHS) reported amortization of debt discount premium of $195K in Q1 2026.
How has PTHS's amortization of debt discount premium changed year-over-year?
PTHS's amortization of debt discount premium increased by 107.4% year-over-year, from $94K to $195K.
What is the long-term trend for PTHS's amortization of debt discount premium?
Over 2 years (2023 to 2025), PTHS's amortization of debt discount premium has grown at a 17.3% compound annual growth rate (CAGR), from $188.12K to $259K.